[Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole].
D000818:Animals; D002981:Clindamycin / Q000627:therapeutic use*; D004338:Drug Combinations; D007933:Leucomycins / Q000627:therapeutic use*; D051379:Mice; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D014124:Toxoplasmosis, Animal / Q000188:drug therapy*; D014295:Trimethoprim / Q000627:therapeutic use*
D004338:Drug Combinations; D007933:Leucomycins; D013424:Sulfanilamides; D002981:Clindamycin; D013413:Sulfadoxine; D014295:Trimethoprim; D013420:Sulfamethoxazole; C026483:midecamycin; D011739:Pyrimethamine
Toxoplasmose expérimentale de la souris. Activité comparée de: clindamycine, midécamycine, josamycine, spiramycine, pyriméthamine-sulfadoxine, et triméthoprime-sulfaméthoxazole.